What is AutoGen?
Headquartered in Holliston, MA, AutoGen operates as a value-added supplier specializing in nucleic acid extraction equipment and sample preparation solutions. Its strategic location near Boston's prominent biotech and research hubs facilitates strong connections within the life science community. The company's offerings are critical for researchers and laboratories requiring precise and efficient methods for biological sample processing, positioning AutoGen as a key player in enabling scientific discovery and diagnostic advancements.
How much funding has AutoGen raised?
AutoGen has raised a total of $412K across 2 funding rounds:
Debt
$150K
Debt
$262K
Debt (2020): $150K with participation from PPP
Debt (2021): $262K led by PPP
What's next for AutoGen?
With the recent major strategic investment, AutoGen is poised for accelerated growth and enhanced market penetration. This capital infusion is expected to fuel advancements in its product development pipeline, potentially leading to next-generation extraction technologies and expanded service offerings. The company's late-stage funding context indicates a focus on solidifying its market leadership, optimizing operational efficiencies, and potentially exploring new geographical markets or strategic partnerships to further its mission in supporting the life science research and diagnostic sectors.
See full AutoGen company page